Lea Wagmann

Tools for studying the metabolism of new psychoactive substances for toxicological screening purposes – A comparative study using pooled human liver S9, HepaRG cells, and zebrafish larvae

Lilian H.J. Richter, Jennifer Herrmann, Anastasia Andreas et al. · Toxicology Letters · 2019 · 54 citations · Full text

Health Sciences, Biochemistry, Zebrafish Larvae +15

In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures

Lea Wagmann, Lilian H.J. Richter, Tobias Kehl et al. · Analytical and Bioanalytical Chemistry · 2019 · 53 citations · Full text

Substance Abuse, Psychoactive Drug, Medicine +10

What is the contribution of human FMO3 in the N -oxygenation of selected therapeutic drugs and drugs of abuse?

Lea Wagmann, Markus R. Meyer, Hans H. Maurer · Toxicology Letters · 2016 · 51 citations · Full text

Psychoactive Drug, Human Fmo3, Medicine +10

How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings—A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae

Lea Wagmann, Fabian Frankenfeld, Yu Mi Park et al. · Frontiers in Chemistry · 2020 · 51 citations · Full text

Bioanalytical Methods for New Psychoactive Substances

Lea Wagmann, Hans H. Maurer · Handbook of experimental pharmacology · 2018 · 47 citations

Psychoactive Drug, Pharmacological Study, Psychiatry +8